Availability: Άμεσα Διαθέσιμο

SARS-CoV-2 Variants and Global Population Vulnerability. Diagnostic Strategies, Vaccine Development, and Therapeutic Management

ISBN: 9781774917589
ISBN: 9781774917589
Εκδόσεις:
Διαστάσεις 23 × 16 cm
Μορφή

Εκδόσεις

Ημ. Έκδοσης

Σελίδες

Έκδοση

Κύριος Συγγραφέας

,

Original price was: 255,00€.Η τρέχουσα τιμή είναι: 240,00€.(Περιλαμβάνεται ΦΠΑ 6%)

Διαθέσιμο - Προπαραγγελία|Διαθεσιμότητα: 23-28 ημέρες

Περιγραφή

SARS-CoV-2, the coronavirus responsible for COVID-19, wreaked havoc on the world; it could both spread easily and mutate rapidly, leading to the decrease in the effectiveness of newly developed vaccines over time. The detection of these mutated variants and the development of more efficient vaccines requires significant effort and increased knowledge in this field. This new book, SARS-CoV-2 Variants and Global Population Vulnerability: Diagnostic Strategies, Vaccine Development, and Therapeutic Management, provides detailed and systemic information regarding the biology and immunophysiology of SARS-CoV-2 and highlights the global vulnerability of the world population to SARS-CoV-2 infection and COVID-19.

The book covers different aspects pertaining to the SARS-CoV-2 variants and their relation to global vulnerability. Chapters discuss the diagnostics, vaccine development, and therapeutic management starting from the zoonotic origin, organization, and transmission of SARS-CoV-2, lifestyle and immunophysiology of the virus, detection and diagnosis techniques, and analytical techniques. The book also observes the global impact of Delta and Omicron SARS-CoV-2 variants. It looks at the drug repurposing and new drug discovery routines for the emerging variants. It presents strategies for fast-track vaccine development, the roles of nasal vaccines and nucleic acid vaccines for COVID-19 management, monoclonal antibody therapy for the diseases management, along with the use of dietary supplements and nutraceuticals, herbal drugs, and other alternative remedies for COVID-19 management. The book also considers the social and environmental impacts of SARS-CoV-2 variants and the current challenges, outlining aspects that can help in developing more efficacious means for controlling SARS-CoV-2 in the future.

Key highlights:

  • Discusses SARS-CoV-2 variants, diagnosis strategies, vaccine development, and the therapeutic management of the disease
  • Provides comprehensive coverage of SARS-CoV-2 virus and variants

With its unique and thorough take on the subject, this book is an important resource of know-how for investigators working in this area. Professionals from the pharmaceutical industry as well as students, research scholars, doctors, and other healthcare professionals will find this book of particular value.

Περιεχόμενα

Foreword by Elrashdy M. Redwan

 

1. Zoonotic Origin, Genomic Organization, Transmission, and Mutation of SARS-CoV-2

Ashutosh Singh, Rehan Fazal, Upasana Sahu, Manoj Kumar, Sandeep Bhatia, Aniket Sanyal, and Naveen Kumar

 

2. SARS-CoV-2 Life Cycle and Immuno-Pathophysiology

Alberto Rubio-Casillas and Vladimir N. Uversky

 

3. Conventional and Novel Diagnostics for the Detection of SARS-CoV-2 Variants

Bruno Andrade, Robinson Sabino-Silva, and Aristóteles Góes-Neto

 

4. Biosensors: An Advanced and Sensitive Analytical Technique for the Early Detection of SARS-CoV-2 Variants

Siva Nageswararao Gajula, Lakshmi Vineela Nalla, and Vivek P Chavda

 

5. Global Impact of Delta and Omicron Variants of SARS-CoV-2

Lawandashisha Nongrang, Rajashri Bezbaruah, Tutumoni Kalita, Kangkan Deka, Bitu Gogoi, and Prativa Sadhu

 

6. Drug Repurposing for Covid-19 and Fast Track New Drug Discovery for Emerging SARS-CoV-2 Variants

Divya Teli, Amit Chaudhari, Disha Patel, and Mahesh Chhabria

 

7. Characterization of SARS-CoV-2 Variants Using Respiratory Organoids and Organs on a Chip (OOACs)

Yukio Watanabe and Kazuo Takayama

 

8. Fast-Track Vaccine Development for Covid-19 and Impact of Emerging Variants

Alaa A. A. Aljabali, Mohammad A. Obeid, and Murtaza M. Tambuwala

 

9. Nasal Vaccine for the Control of Emerging Variants of SARS-CoV-2

Anup Kumar, Dixa A. Vaghela, Pankti C. Balar, Kajal Bhavisker, Rajashri Bezbaruah, Lawandashisha Nongrang, Anjali P. Bedse, and Vivek P. Chavda

 

10. Role of Nucleic Acid Vaccines for the Management of Emerging Variants of SARS-CoV-2

Kenneth Lundstrom

 

11. Role of Monoclonal Antibodies for the Management of Immersing Variant of SARS-CoV-2

Vivek P. Chavda, Hetvi K. Solanki, Subhash C. Chauhan, and Murali M. Yallapu

 

12. Dietary Supplements and Nutraceuticals Against Variants of SARS-CoV-2

Amit Z. Chaudhari, Divya Teli, Pankti C. Balar, Jimil Gandhi, and Vivek P. Chavda

 

13. Herbal Remedies for Covid-19 Management

Hitesh Malhotra, Amrit Sarwara, Vandana Garg, Rohit Dutt, Vineet Mittal, and Rajeev K. Singla

 

14. Covid-19 and Post-Covid-19 Associated Complications and Their Management

Mit Joshi and Bhoomika M. Patel

 

15. SARS-CoV-2 Variants and Global Vulnerability: Diagnostic, Vaccines, and Therapeutic Management

Rasha M. Bashatwah, Alaa A. A. Aljabali, and Murtaza M. Tambuwala

 

16. Socio-Economic and Environmental Impact of SARS-CoV-2 Variants

Altijana Hromiæ-Jahjefendiæ, Vivek P. Chavda, and Lakshmi Vineela Nalla

 

17. Nanotechnology-Based Interventions for Covid-19 Management

Vivek P. Chavda, Akta Vaishnav, Kavindra Kumar Kesariand, and Bruce D. Uhal

 

18. SARS-CoV-2 Variants and Covid-19 Pandemic: Future Perspectives

Vivek P. Chavda and Vladimir N. Uversky